Mirum Pharmaceuticals, Inc. · NASDAQ:MIRM
Peetz Christopher sold 30,000 Mirum Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Peetz Christopher (Director, CHIEF EXECUTIVE OFFICER) sold 30,000 Mirum Pharmaceuticals, Inc. shares at an average US$98.68 for US$2.96M under a trading plan, leaving 194,440 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 30,000 shares
- Price
- US$98.68 average (US$98.08 to US$98.91)
- Value
- US$2.96M
- Holding after
- 194,440 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Option exercise | 30,000 | US$2.94 | 224,440 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 8,312 | US$98.08 | 216,128 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 21,688 | US$98.91 | 194,440 | Direct |
Source
Related
- Mirum Pharmaceuticals, Inc.
- Peetz Christopher
- Mirum Pharmaceuticals, Inc. shareholders
- Form 4 · Peetz Christopher · Oct 6, 2026
- Form 4 · Peetz Christopher · Aug 11, 2026
- Form 4 · Peetz Christopher · Jul 8, 2026
- Form 4 · Peetz Christopher · Jun 2, 2026
- Form 4 · Howe Jolanda · Oct 19, 2026
- Form 4 · Bjerkholt Eric · Sep 15, 2026
- Form 4 · Howe Jolanda · Sep 3, 2026
- Form 4 · Howe Jolanda · Aug 19, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026